Remaining questions regarding the use of adjuvant chemotherapy in breast cancer

Unanswered questions in the use of adjuvant therapy in early breast cancerПодробнее

What's New in Screening and Treatment for Lobular Breast CancerПодробнее

Remaining questions regarding the use of frontline CDK4/6 inhibitors and endocrine therapyПодробнее

Ask The Expert: SABCS HighlightsПодробнее

Molecular Classification of Endometrial Cancer and Targeted Therapy ConsiderationsПодробнее

Case-based clinical update in Lung Cancer | 2023 Community Cases MemphisПодробнее

Remaining questions on the use of frontline CDK4/6 inhibitors + endocrine therapyПодробнее

Adjuvant Chemotherapy, Immunotherapy and Metronomic Therapy - New Directions - Prof.Govind BabuПодробнее

Neoadjuvant and adjuvant therapy of Sarcoma- Dr Senthil RajappaПодробнее

GI ASCO 2020 Recap WebinarПодробнее

ASCO Breast Cancer Update | Jane Meisel, MD | 2022 Review and Renew SedonaПодробнее

Adjuvant Therapy of Breast CancerПодробнее

Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the WayПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Reshma MahtaniПодробнее

Evaluation of Breast Specimens after Neoadjuvant ChemotherapyПодробнее